Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mexiletine in sporadic amyotrophic lateral sclerosis
NCT01849770Phase 2Completed
- Sponsor
- University of Washington
- Start
- Jul 2013
- Primary completion
- Aug 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mexiletine in amyotrophic lateral sclerosis (ALS), sponsored by University of Washington. Started Jul 2013; status: completed.
02
Drugs
mexiletine
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT01849770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01849770.